semaglutide and fatty liver Focus on 2.4 mg/week for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis Semaglutide (Wegovy) Improves MASH in

No needles, no downtimejust transformative results that fit seamlessly into your lifestyle

13 CarusoIGiorginoF

Another challenge lies in long-term adherence

Mounjaro sulphur burps are nothing to worry about in most cases they tend to ease off as the body adapts to the medication

Originally developed for the treatment of type 2 diabetes, Wegovy has demonstrated exceptional effectiveness in helping individuals lose excess weight and improve their overall health

Several licensed weight management injectable therapies are available in the UK including semaglutide (Wegovy, approved by NICE for weight management in eligible adults) and tirzepatide (Mounjaro, licensed in the UK for type 2 diabetes and, subject to current NICE guidance, for weight management in eligible adults)